Prognosis of Immune-related Adverse Events in Patients With Advanced Gastric Cancer Treated With Nivolumab or Pembrolizumab: A Multicenter Retrospective Analysis

Conclusion: The occurrence of irAEs was associated with a better clinical outcome of ICIs in patients with AGC.

Source: In Vivo - January 5, 2021 Category: Research Authors: ANDO, T., UEDA, A., OGAWA, K., MOTOO, I., KAJIURA, S., NAKAJIMA, T., HIRANO, K., OKUMURA, T., TSUKADA, K., HARA, T., SUZUKI, N., NAKADA, N., HORIKAWA, N., FUJII, T., YASUDA, I. Tags: Clinical Studies Source Type: research